Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma pharmacokinetics of temocillin in urinary tract infection patients with renal impairment
2021-005741-32Phase 4Completed
- Sponsor
- UCLouvain
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of temocillin in urinary tract infection (UTI), sponsored by UCLouvain. Primary endpoint: Plasma pharmacokinetics after 4th temocillin dose. Started Dec 2021; status: completed.
02
Drugs
temocillin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2021-005741-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005741-32.